Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Fulcrum TherapeuticsGeronLannettCannTrustRecro Pharma
SymbolNASDAQ:FULCNASDAQ:GERNNYSE:LCINYSE:CTSTNASDAQ:REPH
Price Information
Current Price$8.89$1.44$14.00C$1.27$11.72
52 Week RangeBuyBuyHoldHoldBuy
Analyst Ratings
Consensus RecommendationBuyBuyHoldHoldBuy
Consensus Price Target$24.00$3.55$14.00C$5.75$12.6250
% Upside from Price Target169.97% upside146.53% upsideN/A352.76% upside7.72% upside
Trade Information
Market Cap$213.10 million$286.40 million$543.05 millionC$212.22 million$267.79 million
BetaN/A2.572.193.55-0.3
Average Volume59,8261,240,8374,079,2452,243,628158,946
Sales & Book Value
Annual RevenueN/A$1.07 million$655.41 millionC$35.22 million$77.35 million
Price / SalesN/A253.570.865.103.40
CashflowN/AN/A$3.9106 per shareN/AN/A
Price / CashN/AN/A3.58N/AN/A
Book ValueN/A$0.95 per share$8.49 per shareC$1.27 per share($0.91) per share
Price / BookN/A1.521.651.00-12.88
Profitability
Net Income$-32,590,000.00$-27,020,000.00$-272,110,000.00C$-10,460,000.00$-79,720,000.00
EPSN/A($0.16)$2.35C($0.11)($2.49)
Trailing P/E Ratio0.00N/A5.96N/AN/A
Forward P/E RatioN/AN/A8.48N/A48.83
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-5,328.80%-41.52%-22.33%-64.26%
Return on Equity (ROE)N/A-22.33%28.00%-6.69%-472.45%
Return on Assets (ROA)N/A-21.47%7.35%-5.71%-18.13%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A1.98%0.01%N/A
Current Ratio8.10%16.86%2.67%5.64%8.66%
Quick Ratio8.10%16.86%1.86%3.38%7.52%
Ownership Information
Institutional Ownership PercentageN/A31.16%98.46%20.71%60.50%
Insider Ownership PercentageN/A7.50%12.57%N/A20.10%
Miscellaneous
Employees62171,020576255
Shares Outstanding23.34 million188.42 million40.41 million141.48 million22.43 million
Next Earnings Date11/25/2019 (Estimated)11/7/2019 (Estimated)11/6/2019 (Estimated)9/24/2019 (Estimated)11/6/2019 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableOptionable
 Fulcrum TherapeuticsGeronLannettCannTrustRecro Pharma

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel